You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

entinostat

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

Suspended
  • Metastatic Cancer
  • Renal Cancer
  • Indianapolis, Indiana
  • +3 more
Oct 29, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • entinostat
  • +3 more
  • Baltimore, Maryland
    University of Maryland Baltimore
Apr 29, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • Entinostat
  • Placebo
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Renal Cell Carcinoma Trial in Washington, Indianapolis (Entinostat, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Entinostat
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 10, 2022

Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
Feb 14, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)

Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
Dec 14, 2021

Neuroendocrine Tumors Trial in New York (Entinostat)

Recruiting
  • Neuroendocrine Tumors
  • Entinostat
  • New York, New York
    Columbia University Medical Center
Oct 6, 2021

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer Trial in Sarasota, Oklahoma City, Nashville (entinostat,

Completed
  • Lung Cancer
  • +3 more
  • entinostat
  • +2 more
  • Sarasota, Florida
  • +2 more
Nov 11, 2021

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Entinostat
  • +2 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Entinostat
  • +4 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021

Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)

Active, not recruiting
  • Advanced Breast Cancer
  • Entinostat
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy Medical Sciences
Jul 7, 2021

Melanoma Trial in Chapel Hill (Entinostat, Pembrolizumab)

Recruiting
  • Melanoma
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
May 8, 2021

Breast Cancer Trial in Georgia, United States (entinostat, atezolizumab, Placebo)

Completed
  • Breast Cancer
  • entinostat
  • +2 more
  • Birmingham, Alabama
  • +28 more
May 9, 2022

Pancreas Cancer Trial (Entinostat, FOLFOX regimen)

Withdrawn
  • Pancreas Cancer
  • Entinostat
  • FOLFOX regimen
  • (no location specified)
Jan 13, 2021

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Entinostat
  • +2 more
  • Tucson, Arizona
  • +29 more
Aug 18, 2022

Breast Cancer, Invasive Breast Cancer, ER-Negative PR-Negative HER2-Negative Breast Cancer Trial in Chapel Hill (Entinostat)

Terminated
  • Breast Cancer
  • +2 more
  • Entinostat
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Mar 22, 2021